Project Grant S10OD038396

Award Date 8/1/25
Completion Date 7/31/26
Dollars Obligated $1.7M
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Charleston, SC 29425, USA
Similar Awards
The National Institutes of Health (NIH) awarded a $1,352,820 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to the Massachusetts General Hospital (MGH) to acquire a novel high-throughput and high-sensitivity mass spectrometer called the Orbitrap Astral. This state-of-the-art instrument will be used to conduct proteomic research focused on cancer and Alzheimer's disease at MGH. The Orbitrap Astral's unprecedented speed and sensitivity are expected to enable new...
This $949,116 Project Grant awarded by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a Thermo Fisher Scientific Orbitrap IQ-X mass spectrometer system with a Vanquish Flex UHPLC system at the University of South Florida (USF). This cutting-edge analytical instrumentation will establish a unique omics capability at USF to support detailed, high-resolution structural analysis of low-level small molecules in complex...
This $1,205,941.00 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) will enable the Salk Institute for Biological Studies to acquire a high-resolution Thermo Fisher Scientific Orbitrap IQ-X Tribrid mass spectrometer. This cutting-edge instrument with an ultrahigh performance liquid chromatography system will significantly enhance the Institute's mass spectrometry capabilities, allowing for more...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $1,089,778 to The Regents of the University of Colorado (CU-Boulder) to purchase a high-resolution liquid chromatography-mass spectrometry system. The new instrument, consisting of a Waters Select Series Cyclic IMS QTOF mass spectrometer, ACQUITY PREMIER UPLC, and ACQUITY HDX Manager UPLC, will support small molecule, biomolecule, and post-translational...
This Project Grant award of $1,980,309 from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) under CFDA 93.351 will fund the acquisition of an Orbitrap Astral mass spectrometer system for the Keck MS & Proteomics Resource at Yale University. The advanced instrument will enable rapid, high-resolution protein identification and quantification, supporting a wide range of proteomics research projects across Yale and external investigators. Key expected...
The National Science Foundation's Integrative Activities (CFDA 47.083) program has awarded a $350,000 Project Grant to the College of Charleston to acquire a MALDI-TOF/TOF mass spectrometer instrument. This state-of-the-art equipment will enable new research directions, encourage cross-disciplinary collaborations, and provide hands-on training for a diverse population of undergraduate students and researchers at the college and across the Lowcountry region of South Carolina. The mass...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $738,090 to the University of California, Irvine (UCI) to purchase a refurbished Orbitrap Eclipse Tribrid mass spectrometer. The new instrument will enable a major user group at UCI to conduct enhanced quantitative protein-based mass spectrometry experiments in support of multiple NIH-funded research programs. Key applications include...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $750,000 to Stanford University to acquire a Bruker timsTOF Flex MALDI-2 mass spectrometer. The instrument will be used to support spatial single-cell omics research at Stanford's Center for Genomics and Personalized Medicine. This state-of-the-art mass spectrometer will enable researchers to study the spatial distribution of small molecules, such as...
This $1,574,994 Project Grant awarded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a high-resolution tandem mass spectrometer to support large molecule structural characterization research at the University of California, Los Angeles (UCLA). The state-of-the-art mass spectrometer, equipped with electrospray ionization and various activation/dissociation methods, will enable advanced analysis of a broad range of...
This $737,124 Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 Biomedical Research and Research Training Program) will enable The Trustees of the University of Pennsylvania to acquire a Thermo Scientific Orbitrap IQ-X Tribrid mass spectrometer coupled to a Vanquish dual column liquid chromatography system. This highly sensitive instrumentation will be used to expand the Translational Biomarker Core's lipidomics, metabolomics, isotope tracing, and...

This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351 - Research Infrastructure Programs) provides $1,658,828 to the Medical University of South Carolina (MUSC) to acquire a Thermo Scientific Orbitrap Astral Mass Spectrometer. This state-of-the-art mass spectrometry instrument will support NIH-funded research across multiple disease areas, including cancer, immunotherapy, cardiovascular disease, liver and digestive disease, neurological disease, and addiction. The new equipment will enhance MUSC's research capabilities by providing faster data acquisition, improved sensitivity, quantitative resolution, and reproducibility of proteomic measurements compared to the university's current instrumentation. This advanced technology is expected to accelerate the discovery of disease mechanisms and insights into therapeutic responses. The award period runs from August 1, 2025 to July 31, 2026.

Generated 8/5/25, 4:24 AM